Stromal upregulation of SOX2 promotes tumorigenesis through the generation of a SFRP1/2-expressing cancer-associated fibroblast population
暂无分享,去创建一个
A. Durán | J. Moscat | E. Batlle | M. Yashiro | J. Linares | M. Reina-Campos | M. Diaz-Meco | M. Ohira | Y. Kudo | H. Kasashima | Daniele V. F. Tauriello | Anxo Martínez-Ordóñez | Y. Nakanishi | Antoine L’Hermitte | Kinoshita | Hiroto | Fei Bao | Maria T. Diaz-Meco | Yotaro Kudo
[1] Y. Cho,et al. Lineage-dependent gene expression programs influence the immune landscape of colorectal cancer , 2020, Nature Genetics.
[2] S. Lowe,et al. Zonation of Ribosomal DNA Transcription Defines a Stem Cell Hierarchy in Colorectal Cancer. , 2020, Cell stem cell.
[3] Y. Kluger,et al. Paracrine orchestration of intestinal tumorigenesis by a mesenchymal niche , 2020, Nature.
[4] R. Jain,et al. A framework for advancing our understanding of cancer-associated fibroblasts , 2020, Nature Reviews Cancer.
[5] A. Vincent-Salomon,et al. Cancer-associated fibroblast heterogeneity in axillary lymph nodes drives metastases in breast cancer through complementary mechanisms , 2020, Nature Communications.
[6] J. Moscat,et al. Serrated Colorectal Cancer: The Road Less Travelled? , 2019, Trends in cancer.
[7] O. De Wever,et al. Fibroblasts Fuel Immune Escape in the Tumor Microenvironment. , 2019, Trends in cancer.
[8] D. Adams,et al. Epithelial NOTCH Signaling Rewires the Tumor Microenvironment of Colorectal Cancer to Drive Poor-Prognosis Subtypes and Metastasis , 2019, Cancer cell.
[9] J. Moscat,et al. The Dual Roles of the Atypical Protein Kinase Cs in Cancer. , 2019, Cancer cell.
[10] Jianmin Wu,et al. Proteomic Profiling of Human Prostate Cancer-associated Fibroblasts (CAF) Reveals LOXL2-dependent Regulation of the Tumor Microenvironment* , 2019, Molecular & Cellular Proteomics.
[11] R. DePinho,et al. KRAS-IRF2 Axis Drives Immune Suppression and Immune Therapy Resistance in Colorectal Cancer. , 2019, Cancer cell.
[12] Weiqi Wang,et al. Taiji: System-level identification of key transcription factors reveals transcriptional waves in mouse embryonic development , 2019, Science Advances.
[13] A. Durán,et al. Simultaneous Loss of Both Atypical Protein Kinase C Genes in the Intestinal Epithelium Drives Serrated Intestinal Cancer by Impairing Immunosurveillance , 2018, Immunity.
[14] Zhenqiu Liu,et al. Heterogeneous cancer associated fibroblast population potentiates neuroendocrine differentiation and castrate resistance in a CD105-dependent manner , 2018, Oncogene.
[15] A. Durán,et al. The Secretion of miR-200s by a PKCζ/ADAR2 Signaling Axis Promotes Liver Metastasis in Colorectal Cancer , 2018, Cell reports.
[16] Paul Hoffman,et al. Integrating single-cell transcriptomic data across different conditions, technologies, and species , 2018, Nature Biotechnology.
[17] R. Bourgon,et al. TGF-β attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells , 2018, Nature.
[18] A. Nebreda,et al. TGF ‐ beta drives immune evasion in genetically reconstituted colon cancer metastasis , 2018 .
[19] Christian M. Metallo,et al. ATF4-Induced Metabolic Reprograming Is a Synthetic Vulnerability of the p62-Deficient Tumor Stroma. , 2017, Cell metabolism.
[20] F. Marincola,et al. Immunogenomic Classification of Colorectal Cancer and Therapeutic Implications , 2017, International journal of molecular sciences.
[21] Hui-Li Qu,et al. Silencing of Prrx2 Inhibits the Invasion and Metastasis of Breast Cancer both In Vitro and In Vivo by Reversing Epithelial-Mesenchymal Transition , 2017, Cellular Physiology and Biochemistry.
[22] Francisco J. Sánchez-Rivera,et al. In vivo genome editing and organoid transplantation models of colorectal cancer , 2017, Nature Biotechnology.
[23] J. Guinney,et al. Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer , 2017, Nature Reviews Cancer.
[24] H. Ikeuchi,et al. Control of Paneth Cell Fate, Intestinal Inflammation, and Tumorigenesis by PKCλ/ι. , 2016, Cell reports.
[25] L. Cantley,et al. Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion , 2016, Nature.
[26] R. Kalluri. The biology and function of fibroblasts in cancer , 2016, Nature Reviews Cancer.
[27] F. Markowetz,et al. Practical and Robust Identification of Molecular Subtypes in Colorectal Cancer by Immunohistochemistry , 2016, Clinical Cancer Research.
[28] Etienne Becht,et al. Immune and Stromal Classification of Colorectal Cancer Is Associated with Molecular Subtypes and Relevant for Precision Immunotherapy , 2016, Clinical Cancer Research.
[29] L. Ferrucci,et al. sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance , 2016, Nature.
[30] Ying Jin,et al. Comprehensive profiling reveals mechanisms of SOX2-mediated cell fate specification in human ESCs and NPCs , 2016, Cell Research.
[31] Jianqing Xu,et al. SFRP2 augments WNT16B signaling to promote therapeutic resistance in the damaged tumor microenvironment , 2016, Oncogene.
[32] Jeffrey S. Morris,et al. The Consensus Molecular Subtypes of Colorectal Cancer , 2015, Nature Medicine.
[33] Camille Stephan-Otto Attolini,et al. Stromal gene expression defines poor-prognosis subtypes in colorectal cancer , 2015, Nature Genetics.
[34] A. Durán,et al. Repression of Intestinal Stem Cell Function and Tumorigenesis through Direct Phosphorylation of β-Catenin and Yap by PKCζ. , 2015, Cell reports.
[35] Christian M. Metallo,et al. Metabolic reprogramming of stromal fibroblasts through p62-mTORC1 signaling promotes inflammation and tumorigenesis. , 2014, Cancer cell.
[36] Yan-xia Lu,et al. Regulation of Colorectal Carcinoma Stemness, Growth, and Metastasis by an miR-200c-Sox2–Negative Feedback Loop Mechanism , 2014, Clinical Cancer Research.
[37] M. Walsh,et al. The PRKCI and SOX2 oncogenes are coamplified and cooperate to activate Hedgehog signaling in lung squamous cell carcinoma. , 2014, Cancer cell.
[38] D. Quail,et al. Microenvironmental regulation of tumor progression and metastasis , 2014 .
[39] Florian Markowetz,et al. Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions , 2013, Nature Medicine.
[40] Aleksey A. Porollo,et al. Control of Nutrient Stress-Induced Metabolic Reprogramming by PKCζ in Tumorigenesis , 2013, Cell.
[41] K. Hochedlinger,et al. The sox family of transcription factors: versatile regulators of stem and progenitor cell fate. , 2013, Cell stem cell.
[42] M. Nieto,et al. Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. , 2012, Cancer cell.
[43] Fabian J Theis,et al. A Unilateral Negative Feedback Loop Between miR-200 microRNAs and Sox2/E2F3 Controls Neural Progenitor Cell-Cycle Exit and Differentiation , 2012, The Journal of Neuroscience.
[44] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[45] Louis Vermeulen,et al. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment , 2010, Nature Cell Biology.
[46] M. Kazanietz,et al. Protein kinase C and other diacylglycerol effectors in cancer , 2007, Nature Reviews Cancer.
[47] S. Yamanaka,et al. Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.
[48] O. Franco,et al. Identification of SFRP1 as a candidate mediator of stromal-to-epithelial signaling in prostate cancer. , 2005, Cancer research.
[49] R. Derynck,et al. Repression of Runx2 function by TGF‐β through recruitment of class II histone deacetylases by Smad3 , 2005, The EMBO journal.
[50] T. Ratliff. TGF-Beta Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia , 2004 .
[51] J. Massagué,et al. E2F4/5 and p107 as Smad Cofactors Linking the TGFβ Receptor to c-myc Repression , 2002, Cell.
[52] A. Durán,et al. Targeted disruption of the zetaPKC gene results in the impairment of the NF-kappaB pathway. , 2001, Molecular cell.